These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18774496)

  • 61. Immunohistochemical localization of transferrin in human breast cancer tissue.
    Agarwal PK; Mehrotra A; Chandra T; Singh K
    Indian J Pathol Microbiol; 2000 Oct; 43(4):441-7. PubMed ID: 11344609
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dual usages of single Wilms' tumor 1 immunohistochemistry in evaluation of breast tumors: a preliminary study of 30 cases.
    Li JH; Man YG
    Cancer Biomark; 2009; 5(3):109-16. PubMed ID: 19407365
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Histochemical study of estradiol receptors and morphologic parameters in breast cancer].
    Berger G; Frappart L; Feroldi J
    Bull Assoc Anat (Nancy); 1982 Dec; 66(195):431-9. PubMed ID: 6305447
    [TBL] [Abstract][Full Text] [Related]  

  • 64. REG1A expression is an independent factor predictive of poor prognosis in patients with breast cancer.
    Sasaki Y; Minamiya Y; Takahashi N; Nakagawa T; Katayose Y; Ito A; Saito H; Motoyama S; Ogawa J
    Ann Surg Oncol; 2008 Nov; 15(11):3244-51. PubMed ID: 18781363
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid.
    Cho Mar K; Eimoto T; Nagaya S; Tateyama H
    Histopathology; 2006 Jun; 48(7):801-7. PubMed ID: 16722928
    [TBL] [Abstract][Full Text] [Related]  

  • 66. DCIS and LCIS with multinucleated giant cells-a report of 4 cases.
    Coyne JD
    Histopathology; 2007 Apr; 50(5):669-71. PubMed ID: 17394507
    [No Abstract]   [Full Text] [Related]  

  • 67. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
    Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
    J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Invasive tubular carcinoma of the breast frequently is clonally related to flat epithelial atypia and low-grade ductal carcinoma in situ.
    Aulmann S; Elsawaf Z; Penzel R; Schirmacher P; Sinn HP
    Am J Surg Pathol; 2009 Nov; 33(11):1646-53. PubMed ID: 19675453
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nuclear localization of cytokeratin 8 and the O-linked N-acetylglucosamine-containing epitope H in epithelial cells of infiltrating ductal breast carcinomas: a combination of immunogold and EDTA regressive staining methods.
    Havaki S; Voloudakis-Baltatzis I; Goutas N; Arvanitis LD; Vassilaros SD; Arvanitis DL; Kittas C; Marinos E
    Ultrastruct Pathol; 2006; 30(3):177-86. PubMed ID: 16825119
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
    Bharat A; Gao F; Margenthaler JA
    Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Analysis of the progression of intraductal proliferative lesions in the breast by PCR-based clonal assay.
    Yu Q; Niu Y; Yu Y; Ding X; Shi Y
    Breast Cancer Res Treat; 2009 Apr; 114(3):433-40. PubMed ID: 18425676
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Changes in subcellular localisation of MI-ER1 alpha, a novel oestrogen receptor-alpha interacting protein, is associated with breast cancer progression.
    McCarthy PL; Mercer FC; Savicky MW; Carter BA; Paterno GD; Gillespie LL
    Br J Cancer; 2008 Aug; 99(4):639-46. PubMed ID: 18665173
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Glycoprotein synthesis as a function of epithelial cell arrangement: biosynthesis and release of glycoproteins by human breast and prostate cells in organ culture.
    Tökés ZA; Dermer GB
    J Supramol Struct; 1977; 7(3-4):515-30. PubMed ID: 211350
    [TBL] [Abstract][Full Text] [Related]  

  • 74. E-cadherin expression in invasive breast cancer.
    Suciu C; Cîmpean AM; Mureşan AM; Izvernariu D; Raica M
    Rom J Morphol Embryol; 2008; 49(4):517-23. PubMed ID: 19050801
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Different estrogen receptor beta expression in distinct histologic subtypes of lung adenocarcinoma.
    Alì G; Donati V; Loggini B; Servadio A; Dell'Omodarme M; Prati MC; Camacci T; Lucchi M; Melfi F; Mussi A; Fontanini G
    Hum Pathol; 2008 Oct; 39(10):1465-73. PubMed ID: 18620727
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast.
    Ichihara S; Fujimoto T; Hashimoto K; Moritani S; Hasegawa M; Yokoi T
    Pathol Int; 2007 Mar; 57(3):126-32. PubMed ID: 17295644
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gp96 and its different expression in breast carcinomas.
    Hodorova I; Rybarova S; Solar P; Vecanova J; Prokopcakova L; Bohus P; Solarova Z; Mellova Y; Schmidtova K
    Neoplasma; 2008; 55(1):31-5. PubMed ID: 18190237
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Minichromosome maintenance proteins are useful adjuncts to differentiate between benign and malignant melanocytic skin lesions.
    Gambichler T; Shtern M; Rotterdam S; Bechara FG; Stücker M; Altmeyer P; Kreuter A
    J Am Acad Dermatol; 2009 May; 60(5):808-13. PubMed ID: 19389522
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
    Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
    Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.